Saturday, May 10, 2025 5/10/2025

Experimentally Testing Legally Feasible Regulatory Options for Reducing the Impact of the Point-of-sale Retail Environment on Adolescent Tobacco Use.

Award Number: R01CA236608
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

Experimentally Testing Legally Feasible Regulatory Options for Reducing the Impact of the Point-of-sale Retail Environment on Adolescent Tobacco Use. - Project Summary Tobacco advertising at retail point-of-sale (POS) includes promotional allowances that permit tobacco products to be advertised and sold at reduced cost to consumers (e.g., two-for-one specials); high visibility sale and therefore placement of hundreds of tobacco products on power walls; and the display of a large, diverse collection of poster advertisements on the exterior of the stores. Adolescents are at significant risk for having repeated exposures to this tobacco rich POS environment and such exposures contribute to increases in adolescent tobacco use. Although curbing the effect of the tobacco rich POS environment on adolescent tobacco use is a critical public health goal, some POS advertising regulations are unlikely to be viable in the United States because they impinge upon the tobacco industry's commercial free speech rights. For example, eliminating the tobacco power wall is probably not a viable option in the US as it has been successfully challenged in court by the tobacco industry. POS regulations that do not violate the industry's commercial free speech rights stand a better chance of being upheld by the courts. For example, eliminating tobacco product price promotions, reducing the availability of tobacco products by restricting the sale of flavored products, and restricting how much door/window space tobacco product posters can occupy at POS, all have been implemented as feasible and legally defensible regulatory options at POS. The evidence base supporting the efficacy of these initiatives is, however, almost non-existent – leaving them open to legal scrutiny. The overall aim of this research is to experimentally evaluate different, legally-viable approaches to reducing the impact of the POS retail environment on adolescent tobacco use risk. We will be investigating the regulations for four classes of tobacco products (cigarettes, e-cigarettes, smokeless tobacco, little cigars/cigarillos). We propose to investigate the extent to which eliminating tobacco product price promotions (Study 1), restricting how much door/window space tobacco posters can occupy at POS (Study 2), and eliminating the sale of flavored and/or mentholated tobacco products (Study 3) reduce adolescent tobacco-use risk. Each study will evaluate gender and race (African-American vs Caucasian) as key moderators of the regulations under investigation. The studies will take place in the RAND StoreLab, a life-sized replica of a convenience store that was developed to experimentally evaluate how altering aspects of tobacco promotion at POS influences tobacco use. These studies stand to provide critical proof-of-concept information on whether incremental (but legally feasible) changes to the POS environment influence adolescent tobacco use and thus, advance regulatory science aimed at helping adolescents resist the powerful, tobacco-rich POS retail environment.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $459,992 )
2023	2023	RAND CORP	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	000	5	3/13/2023	NON-COMPETING CONTINUATION	$459,992
														Subtotal = $459,992

Issue Date FY: 2022 ( Subtotal = $533,132 )
2022	2022	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	000	4	3/21/2022	NON-COMPETING CONTINUATION	$489,608
2022	2022	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	001	4	6/21/2022	NON-COMPETING CONTINUATION	$43,524
														Subtotal = $533,132

Issue Date FY: 2021 ( Subtotal = $532,861 )
2021	2021	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	000	3	3/24/2021	NON-COMPETING CONTINUATION	$532,861
														Subtotal = $532,861

Issue Date FY: 2020 ( Subtotal = $526,635 )
2020	2020	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	000	2	3/31/2020	NON-COMPETING CONTINUATION	$526,635
														Subtotal = $526,635

Issue Date FY: 2019 ( Subtotal = $483,709 )
2019	2019	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	000	1	4/9/2019	NEW	$493,735
2019	2019	RAND CORPORATION, THE	1776 MAIN ST	SANTA MONICA	CA	90401	LOS ANGELES	USA	Cancer Cause and Prevention Research	001	1	7/4/2019	NEW	-$10,026
														Subtotal = $483,709

Grand Total All Awards = $2,536,329

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Experimentally Testing Legally Feasible Regulatory Options for Reducing the Impact of the Point-of-sale Retail Environment on Adolescent Tobacco Use.

Award Number: R01CA236608

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer